搜尋結果
Here Are the Obesity Drug Hopefuls Vying to Unseat Ozempic, Zepbound
Bloomberg· 2 日前Insatiable demand for weight-loss drugs has made the market so feverish that any positive ...
TD Risks an Earnings Hit From US Laundering Probe, Analysts Say
Bloomberg· 2 日前With new allegations emerging surrounding US anti-money-laundering investigations into ...
FTC Seeks More Information on $16.5 Billion Novo-Catalent Deal
The Wall Street Journal· 2 日前The request signals that the agency is reviewing whether the deal could be anticompetitive ...
This rare muscle disease play can rally more than 50%, BofA says
CNBC· 2 日前Avidity Biosciences stock has more room to run thanks to the company's pipeline of multiple ...
Jim Cramer's top 10 things to watch in the stock market Friday
CNBC· 2 日前My top 10 things to watch Friday, May 3 The Dow , the S & P 500 and the Nasdaq set to surge at ...
Wegovy maker Novo Nordisk extends losses following first-quarter results
CNBC· 2 日前Shares of Danish pharmaceutical giant Novo Nordisk slid 2.5% on Friday, extending a 2.7% loss ...
Colombia breaks diplomatic ties with Israel but its military relies on key Israeli-built equipment
Bastillepost· 2 日前Colombia has become the latest Latin American country to announce that it will break diplomatic ...
Stocks making the biggest moves premarket: Apple, Amgen, Cloudflare and more
CNBC· 2 日前Shares of the chocolate confectionary maker added about 1% after Hershey posted a first-quarter ...
Here are Friday's biggest analyst calls: Apple, Target, Coinbase, Berkshire Hathaway, Estee ...
CNBC· 2 日前Here are the biggest calls on Wall Street on Friday: RBC initiates FTAI Aviation as outperform ...
Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
The Wall Street Journal· 2 日前Amgen’s progress on its experimental weight-loss drug offered investors a reminder that Novo Nordisk ...